HTAC Guidance: Self-Administered Antigen Test Kits (SAAgT)
The HTAC and its review of health technologies To ensure equitable access to quality and affordable health care to Filipinos, the Health Technology Assessment Council (HTAC) was created under the Universal Healthcare Act of 2019 (Republic Act No. 11223). The HTAC provides technical guidance on the optimal use of health technologies including clinical equipment and devices (i.e., medical continue reading : HTAC Guidance: Self-Administered Antigen Test Kits (SAAgT)
Second Booster of COVID-19 Vaccines for the Prevention of COVID-19 Among Individuals Aged 50 Years Old and Older and Individuals with Comorbidities Aged 18 to 49 Years Old
Date of SOH Approval: 26 August 2022 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of Second Booster of COVID-19 vaccines continue reading : Second Booster of COVID-19 Vaccines for the Prevention of COVID-19 Among Individuals Aged 50 Years Old and Older and Individuals with Comorbidities Aged 18 to 49 Years Old
Revised HTAC Preliminary Recommendation on the Inclusion of Insulin Glargine and the Non-Inclusion of Insulin Detemir in the PNF
Link to appeals form here: Topic Nomination (stakeholders may submit appeals to hta@doh.gov.ph until 07 September 2022.) Document Preview: